文献速递垂体与肾上腺疾病骨质疏松与钙磷/甲状旁腺

近期诊断肢端肥大症患者中与术前生长激素水平相关的椎体骨折高患病率

High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

本研究纳入92例近期诊断的肢端肥大症患者,术前经胸片评估形态学椎体骨折(VF),并与无继发性骨质疏松和垂体疾病的对照比较。患者VF患病率33.7%,显著高于对照组(P=.001);多发VF占38.7%,中重度VF占16.1%。有VF者随机血清GH更高(P=.03),多因素分析GH独立与VF风险相关(P=.003),预测VF的术前GH切点为12 ng/mL。

要点

  • 近期诊断肢端肥大症患者椎体骨折患病率为33.7%,显著高于对照组(P=.001)。
  • 有椎体骨折者随机血清GH高于无骨折者(P=.03),多因素分析GH独立相关(P=.003)。
  • 预测椎体骨折的术前血清GH切点为12 ng/mL。

核心结论

  • 首次报告近期诊断肢端肥大症患者中影像学椎体骨折高患病率,提示椎体骨折可能是肢端肥大症的早期现象并与GH水平相关,诊断肢端肥大症时应将椎体骨折评估纳入检查。

研究设计与样本

  • 纳入92例(男43例/女49例)入住神经外科、经蝶手术前的新诊断肢端肥大症患者,并与无继发性骨质疏松和垂体疾病的对照个体比较。
  • 基于术前胸部X线图像进行椎体骨折评估,并收集生化、人口学和临床数据。

主要发现

  • 肢端肥大症患者椎体骨折患病率为33.7%,显著高于对照组(P=.001)。
  • 合并椎体骨折的肢端肥大症患者中,12例(38.7%)为多发椎体骨折,5例(16.1%)为中重度椎体骨折。
  • 有椎体骨折者随机血清生长激素(GH)水平高于无椎体骨折者(P=.03),但胰岛素样生长因子-1(IGF-1)(P=.07)及IGF-1/正常上限比值(P=.08)无差异。
  • 有椎体骨折的肢端肥大症患者游离三碘甲状腺原氨酸略低于无椎体骨折者(P=.05)。
  • 多因素logistic分析中,GH独立与椎体骨折风险相关(P=.003),预测椎体骨折的术前血清GH切点为12 ng/mL。

临床怎么用

  • 作者认为诊断肢端肥大症时应将椎体骨折评估纳入检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Osteopathy and morphometric vertebral fractures (VFs) are emerging complications in acromegaly. However, the prediction of VFs in this clinical setting is still a matter of uncertainty, and it is debated whether they are an early event in the natural history of the disease. OBJECTIVE: We aimed to evaluate the prevalence and determinants of morphometric VFs in patients with recently diagnosed acromegaly. METHODS: We enrolled 92 patients (43 men/49 women) on admission to the neurosurgery unit before transsphenoidal surgery, and compared them with control individuals without secondary forms of osteoporosis and pituitary disorders. We performed a VF assessment on preoperative chest x-ray images and collected biochemical, demographic, and clinical data. RESULTS: We detected a significantly higher prevalence of VFs (33.7%) in patients with acromegaly than in controls (P = .001). Among the patients with acromegaly and VFs, 12 (38.7%) showed multiple VFs, and 5 (16.1%) showed moderate/severe VFs. Patients with VFs had higher random serum growth hormone (GH) levels than those with no VFs (P = .03), but there was no difference in insulin-like growth factor-1 (IGF-1) (P = .07) and IGF-1/Upper Normal Limit ratio (P = .08). Free 3,5,3'-triiodothyronine was slightly lower in patients with acromegaly and VFs than in those without VFs (P = .05). In multiple logistic analysis, GH was independently associated with risk for VFs (P = .003). The preoperative serum GH cutoff value that predicted VFs was 12 ng/mL. CONCLUSION: For the first time, high prevalence of radiological VFs is reported in patients with recent diagnosis of acromegaly. Therefore, we can hypothesize that VFs are an early phenomenon of acromegaly and related to GH levels. VF assessment should be included in the workup at the diagnosis of acromegaly.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Frara S, Melin Uygur M, di Filippo L, et al. High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly. J Clin Endocrinol Metab. 2022. PMID: 35349698. doi:10.1210/clinem/dgac183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。